Currently there is no consensus for the best treatment in cases of aortic graft infection. This study shows that graft removal and in line autologous deep vein reconstruction is a valid option with acceptable post-operative mortality, a very low re-infection rate, and good graft patency rates even in cases of aorto-enteric fistulas.
INTRODUCTION
Aortic graft infection is the most dreaded complication in vascular surgery, carrying a mortality rate of 25e60% and a limb loss rate of up to 25%. 1e4 Despite antibiotic prophylaxis and meticulous technique, 0.6e4.5% of aortic prostheses become infected. 4e7 To eradicate the infection, the prosthetic graft must be explanted and debrided while maintaining the lower limb arterial circulation. Graft excision and revascularization with axillo-bi-femoral bypass has been the "gold standard", but due to high complication rates, in situ reconstructions are gaining popularity. 8e10 The goal of using antibiotic bonded prostheses, cryopreserved allografts, or autologous femoral vein (FV) grafts for revascularization is to provide better graft durability and limb salvage, fewer re-infections and thereby better longterm survival and quality of life.
The aim of this study is to report a single center's results in treating aortic graft infection (AGI) with graft excision and in situ revascularization with an autologous venous neoaorto-iliac system (NAIS).
MATERIAL AND METHODS
Patients treated surgically for AGI at Helsinki University Hospital between October 2000 and March 2013 were analyzed retrospectively. Only patients treated with NAIS were included in the study. Data on the study patients were collected from a computerized database and manually from patient charts.
Data for demographic parameters, associated comorbidities, indications for the primary procedure, clinical presentation, C-reactive protein (CRP), surgical management, bacteriological culture, post-operative complications, and follow up details were collected. Data on surgical management included location of the aortic clamp, type of vascular reconstruction, presence of aorto-enteric erosion/ fistulae (AEF), and any concomitant gastrointestinal procedure, operative time, and blood loss. Post-operative data were collected on complications and 30 day mortality. During the follow up, limb swelling, limb salvage, durability of venous grafts, re-infection rate, and overall mortality were evaluated.
Pre-operative workup
All patients, except one emergency case, had pre-operative contrast enhanced computed tomography angiography (CTA) and/or magnetic resonance imaging (MRI) carried out for AGI diagnosis. In cases of doubt, an indium-111 tagged leukocyte scan was used in 15 cases and 18 F-fludeoxyglucose positron emission tomography/CT in five cases for confirmation. Femoral veins were evaluated with duplex ultrasound pre-operatively for assessing the diameter (!6 mm) and excluding post-thrombotic changes or anomalies. Early in the series, the ankle brachial index for assessing lower limb perfusion was established, but since 2011 all patients have been scanned with either magnetic resonance angiography (MRA) or CTA when distal pedal pulses were missing. Elective patients had pre-operative visits with an anesthesiologist and internist for cardiopulmonary risk assessment, and additional cardiopulmonary workup was carried out before surgery when necessary. The highest value of CRP between primary symptoms and final diagnosis was collected as a biological sign of severity of the infection. The second value of CRP was collected on the day of NAIS reconstruction. Antimicrobial therapy was started preoperatively based on bacteriological cultures if available, or empirical cefuroxime and vancomycin were administered. When AEF was diagnosed, metronidazole was added.
Diagnosis was based on clinical symptoms, blood samples, and positive findings in at least one imaging modality. The diagnosis was confirmed intra-operatively, when infected fluid around the prosthetic graft was present or the graft was dissected loose from surrounding tissues by infection.
Operative technique
For NAIS, FVs were harvested from popliteal fossa to femoral confluence, leaving the deep FV patent for venous drainage. Side branches were ligated and secured with clips. The first 20 grafts were used in a reversed manner; later on veins were everted and valves excised under direct vision. In most cases, grafts were split proximally and sewn together to match the aortic diameter in a "pantaloon" configuration with 4-0 polypropylene suture. Simultaneously, an infected graft was exposed by a midline (n ¼ 44) or thoraco-lumbar incision (n ¼ 11) and anastomoses were identified. After heparinization the aorta and graft limbs were clamped, grafts were excised, and clearly infected tissue was debrided. The proximal anastomosis of NAIS was reinforced with a piece of tensor fascia lata ( Figs. 1 and 2 ). If there was obvious pus present, the tunnels were flushed with hydrogen peroxide and saline before a new graft was inserted. In a vast majority of cases, distal anastomoses were performed in the groin and covered with a sartorius myoplasty. In a few cases of graft limb shortage, the limb was continued with a saphenous spiral graft or the anastomosis was done more proximally to the iliac artery while closing the femoral artery with a venous patch. When AEF was present, intestinal resection or suture repair was performed by a gastric surgeon. The NAIS was covered with retroperitoneal tissue or omentoplasty and drains were left into the abdominal cavity and to both sartorius muscle pockets.
Post-operatively, low-molecular-weight heparin was administered and intermittent pneumatic pumps were used to prevent thromboembolic complications and excessive swelling due to FV harvest.
Statistical analysis
Continuous variables are expressed as mean (SD, range) or median. Univariate analysis was performed to analyze the risk factors (gender, diabetes, hypertension, coronary disease, chronic obstructive pulmonary disease, uremia, smoking, suprarenal clamp position, AEF, emergency operation, operation time, and blood loss) for 30 day, 90 day, and overall mortality using a chi-square test and unadjusted Cox proportional hazards model. Multivariate analysis was performed with binary logistic regression (30 day and 90 day mortality) and Cox analysis (overall survival) using the following variables: emergency versus elective surgery, suprarenal versus infrarenal clamping, blood loss, and operation time. None of the variables was associated with 30 day or in hospital mortality. Survival was estimated with KaplaneMeier analysis. SPSS package 19.0.0.1 (SPSS Inc., College Station, TX, USA) was used for statistical calculations.
RESULTS
From October 2000 to March 2013, 73 aortic prosthetic infections were diagnosed at Helsinki University Hospital. Because of the patient's poor physical condition, limited clinical findings, or advanced malignant disease, nine patients were treated conservatively. Of the 64 surgically managed patients, one underwent total graft excision and in situ reconstruction with a prosthetic graft due to profound hemorrhagic shock, and another received cryopreserved allografts because deep vein harvest was refused. In seven cases local excision and reconstruction with either allografts or prostheses were performed because of very advanced age or extensive comorbidities. Fifty-five patients were treated by graft excision and NAIS. Only these 55 were included in the study. There were 42 (76%) men and 13 (24%) women with a mean age of 67 AE 15 years. The demographic details are presented in Table 1 .
The median time from primary aortic reconstruction to diagnosis of infection was 32 months (10 days to 288 months); 10 (18%) were early infections and two of them had mycotic aneurysms as the primary indication. The most common symptoms were fever and groin infection. Thirtyone (56%) patients had CRP values over 50 mg/L at the time of diagnosis and nine (16%) on the day of the NAIS ( Table 2 ). The indication for primary aortic reconstruction was atherosclerotic occlusion in 29 (53%), aneurysm disease in 25 (45%), and tumor infiltration in one (2%).
For five (9%) patients, NAIS was reconstructed as an urgent procedure within 24 hours of hospital admission. One AEF patient in hemorrhagic shock was treated first with an aortic endograft and then by NAIS one month later.
Operative data
The median operation time was 7.2 hours (4.5e11.8) and mean blood loss 5.6 AE 4.1 L. In three cases, pieces of the original graft were left behind because of tight attachment to the surrounding tissues and lack of obvious signs of infection. In the remaining 52 cases, graft material was removed completely. The majority of the patients underwent either aorto-bi-femoral (n ¼ 33) or aorto-bi-iliac (n ¼ 13) reconstruction with NAIS (Table 2) . Suprarenal clamping was used in 27 (49%) patients.
In four patients, femoro-popliteal venous reconstructions were done simultaneously with aortic reconstruction, and in two patients it was bilaterally. One patient underwent concomitant trans-femoral amputation. Eighteen patients (33%) required intestinal repair because of AEF.
Microbiology
The most common bacteria isolated were coagulase negative staphylococci strains and Staphylococcus aureus (Table 3 ). In 16 (29%) cases, bacterial growth remained negative, 21 (38%) patients had a mono-bacterial infection, and 18 (33%) a polymicrobial infection. Post-operatively parenteral antimicrobial therapy was administered for at least 6 weeks based on the susceptibility of the isolated strains. The duration of antimicrobial therapy was decided individually based on total or partial graft removal, strains isolated, clinical severity of the infection, and post-operative course of events. Two patients continued with lifelong antibiotic therapy because some prosthetic material remained.
Surgical complications
During the post-operative period, 12 (22%) patients suffered lower limb ischemic complications; in four cases the problem was bilateral and five of them needed fasciotomy. Two (4%) patients developed lower extremity compartment syndrome due to venous hypertension, which also resolved with fasciotomy (Table 4) .
Six (11%) gastrointestinal and six (11%) partial or total iatrogenic ureteric lesions were treated surgically. One bilateral hydronephrosis due to retroperitoneal hematoma was stented.
Outcomes
The mean follow up time was 32 months (1e157 months). The 30 day mortality was five (9%) and the in hospital mortality was eight (15%) ( Table 5 ). All cause mortality in April 2014 was 22 (40%) and overall treatment related mortality 10 (18%). Three patients (5%) required major amputation during the post-operative period, and one patient on arrival. One more patient underwent amputation 9 months after surgery due to critical limb ischemia with a patent aortic graft. In five cases, the NAIS operation was urgent, two of these patients died in the hospital. There were three (5%) graft ruptures, two (4%) due to infection and one due to graft size mismatch, which was treated with venous patches. One of the re-infection patients had graft rupture in the early post-operative phase, while suffering several episodes of peritonitis due to patchy intestinal necrosis and purulent discitis. He developed an AEF 2 months after endovascular treatment of a ruptured mycotic abdominal aortic aneurysm, was operated with NAIS reconstruction, but never recovered from sepsis and died on the 37th post-operative day as a result of peritonitis. In the second case, AEF was diagnosed 96 months after the primary aorto-bi-femoral reconstruction. Two years after NAIS reconstruction he had developed a new AEF. Because of his poor general condition, a palliative EVAR was performed. He died 3 months later from gastrointestinal hemorrhage. Neither of the re-infections appeared in patients with partial graft removal. Nine (16%) patients needed later intervention on vein graft limb, seven due to stenosis and two due to anastomotic pseudoaneurysms. One of them suffered a massive pulmonary embolism after the pseudoaneurysm operation and died, making the overall graft related mortality 18% (n ¼ 10). One graft limb was occluded due to graft stenosis and another due to common femoral artery obstruction. Chronic edema from venous harvesting appeared in six patients (11%); it was mild in all cases and asymptomatic with compression stocking use.
The overall KaplaneMeier survival estimates were 90.7% for 30 days, 81.5% for 1 year, and 59.3% for 5 years. Freedom from graft interventions was 100%, 91.3%, and 77.9% respectively (Fig. 3) . In univariate or multivariate analysis, there were no risk factors associated with the 30 day, 90 day, or overall mortality.
DISCUSSION
Aortic graft infection is a devastating complication, requiring explant of the infected graft and lower limb revascularization for eradication. Using the FV for NAIS reconstruction is complex, but has proven its feasibility in clinical practice with low re-infection rates, good patency, and acceptable morbidity and mortality. After experiencing re-infection problems with a few prosthetic graft reconstructions, it was decided to change to autologous material in 2000. Fifty-five NAIS reconstructions with a 30 day mortality of 9%, in hospital mortality of 15%, and a long-term treatment related mortality of 18% have been observed. Re-infections of the aortic graft occurred in two septic patients with AEF. Only two venous graft limbs were occluded during follow up and the long-term limb salvage rate was 91%. NAIS was introduced by Clagett et al. 11 and Nevelsteen et al. 12 in the early 1990s as an alternative to the extraanatomic bypass because of high complication rates. Their reported low in hospital mortality of 7e10%, an amputation rate of 4e10%, graft patency of 96e100%, and no reinfections remained similar in later reports and in the current one. 13e15 The operative technique has not changed much, except from 2005 we added fascial strengthening to the upper anastomosis. Fascia lata is a good support material in contaminated fields, 16, 17 performing well and reinforcing the anastomosis between thin walled vein and fragile aorta, and diminishing the suture line bleeding.
AEF is an even more complex entity with a high incidence of re-infection and considerable risk of death in cases of acute bleeding and sepsis. 18 Every third patient in this series had an AEF (n ¼ 18, 33%). Both patients who sustained reinfection had AEF initially. The in hospital mortality for AEF patients was 22% (n ¼ 4) and the overall 5 year mortality was 44% (n ¼ 8). Such patients are often nutritionally depleted, immunologically compromised, and may present with septic shock or active gastrointestinal bleeding, thereby having higher mortality rates regardless of which therapeutic option is used.
18e21 Treatment with an aortic endograft (EVAR) for AEF has shown encouraging early results, but long-term mortality due to re-infection is 69e 83%. 19, 22 Therefore, EVAR can be suggested as a bridging technique only. 19, 20, 22 In this series, EVAR was used for one hemodynamically unstable AEF patient and NAIS reconstruction was performed 1 month later without complications.
Autologous FVs with a large caliber are an appealing graft material for aortic reconstructions. Despite intimal hyperplasia and possible subsequent stenosis, their durability is good and graft procedures are still relatively uncommon. Cumulative primary patency rates at 5 years are more than 80% and assisted primary/secondary patency rates more than 90%. 14, 23 The primary patency in this series was 84% and the primary assisted/secondary patency 96%.
The use of allografts shortens the operation time and causes less surgical trauma in cases of AGI, but aneurysmal graft degeneration, disruption with possible re-infections, and availability and cost have been the limiting factors for widespread use. 21,24e28 Resistance to re-infections and graft durability have improved with cryopreservation techniques, making them almost similar to autologous material. Allograft impregnation with neomycin before implantation might reduce re-infections and AEF recurrence further. 27 The amputation rates of 0e7% seem to challenge other treatment methods, but the post-operative mortality of 13e28% and the 5 year survival of 50e55% do not show their overall long-term superiority.
24e26,28,30 Silver-coated or rifampicin bonded prosthetic grafts can also be used for in situ reconstruction. Bisdas et al. 29 compared cryopreserved allografts with silver coated Dacron grafts and reported post-operative mortality, 2 year mortality, and reinfection rates of 14% versus 18%, 18% versus 27% and 0% versus 18%, respectively, but the number of patients in these studies was very low (20 vs. 11) . In cases of minimal or no purulence in the operating field, prosthetic grafts can also perform well. 31, 32 Careful omental coverage of the prosthetic graft is essential and life-long antibiotics should be used. 32 Because of poor long-term results, extra-anatomic prosthetic bypass is not any longer the treatment of choice. 8, 9 Seeger et al. 9 showed that for stable patients, staged procedures can diminish the post-operative mortality rate to 11%, treatment related mortality to 19%, and even stump blowout and re-infections to 3%, but the 5 year primary patency of 64% still remains low.
Among 55 NAIS patients at the Helsinki University Hospital, no single risk factor predictive of post-operative mortality was found. Even though age, end stage renal disease, CRP values of >50 mg/L, an emergency operation and coronary disease have been presented as such in the literature, no association was found in this cohort. 20, 28, 33 In this institution, once surgical treatment is considered, the first choice is autologous NAIS. It performs well in situations with excessive perigraft pus and MRSA, with AEF and has good long-term patency. In cases of inadequate autologous graft material or poor physical condition, cryopreserved allografts are preferred, acknowledging the possible compromise in long-term results.
The main limitation of the study was a lack of comparison between this method and other techniques. However, the incidence of AGI is very low and organizing an international multicenter randomized trial would be extremely difficult to carry out with so few patients per institution. Also, the retrospective nature of the study leads to lack of information on variables such as objective evaluation of limb swelling after surgery and the duration of in hospital stay for patients discharged from other hospitals. The relatively small number of patients in the report probably compromises the statistical analysis of the results.
CONCLUSION
There is still no evidence to prove that one type of treatment is superior to others in cases of AGI. The choice of treatment modality must therefore be tailor made, taking into consideration the patient's condition, the severity of infection, the availability of different reconstructions, and the surgeon's experience. This experience of in situ reconstruction with autologous FVs demonstrates an acceptable rate of morbidity and mortality, thereby for the time being, remaining the preferred reconstructive method at Helsinki University Hospital.
